HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.
- DOI
- 10.3389/fimmu.2020.590072
- Published
- 2020
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2020.590072,
title = {HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.},
author = {Maharaj K and Powers JJ and Mediavilla-Varela M and Achille A and Gamal W and Quayle S and Jones SS and Sahakian E and Pinilla-Ibarz J},
year = {2020},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2020.590072},
url = {https://doi.org/10.3389/fimmu.2020.590072}
}RIS
TY - JOUR TI - HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model. AU - Maharaj K AU - Powers JJ AU - Mediavilla-Varela M AU - Achille A AU - Gamal W AU - Quayle S AU - Jones SS AU - Sahakian E AU - Pinilla-Ibarz J PY - 2020 JO - Frontiers in immunology DO - 10.3389/fimmu.2020.590072 UR - https://doi.org/10.3389/fimmu.2020.590072 ER -
APA
K, M., JJ, P., M, M., A, A., W, G., S, Q., SS, J., E, S., & J, P. (2020). HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2020.590072
Source records
- pubmed · retrieved 2026-09-27T09:40:24.391Z